Search Results - "Quan, M L"

Refine Results
  1. 1

    Perspectives of substitute decision‐makers and staff about person‐centred physical activity in long‐term care by Chu, Charlene H., Quan, Amanda M. L., Gandhi, Freya, McGilton, Katherine S.

    “…Introduction This paper aims to explore the care processes that best exemplify person‐centred care during physical activity (PA) for long‐term care (LTC)…”
    Get full text
    Journal Article
  2. 2

    Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World by Karim, S., Xu, Y., Kong, S., Abdel-Rahman, O., Quan, M.L., Cheung, W.Y.

    “…Strict oncology clinical trial eligibility criteria can contribute to low accrual and result in poorly generalisable study findings. Using common eligibility…”
    Get full text
    Journal Article
  3. 3

    Evaluating the organization and delivery of breast cancer services : use of performance measures to identify knowledge gaps by GAGLIARDI, A, WRIGHT, F. C, QUAN, M. L, MCCREADY, D

    Published in Breast cancer research and treatment (01-06-2007)
    “…This paper identifies gaps in our knowledge about the quality of breast cancer care in Canada to understand where programs and resources are required to…”
    Get full text
    Journal Article
  4. 4

    Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination by Wilson, Lindsay A, Quan, Amanda M L, Bota, A Brianne, Mithani, Salima S, Paradis, Michelle, Jardine, Cindy, Hui, Charles, Pottie, Kevin, Crowcroft, Natasha, Wilson, Kumanan

    Published in BMC family practice (09-01-2021)
    “…Human Papillomavirus (HPV) is the most common sexually transmitted infection in Canada and around the world. Vaccination is an effective prevention strategy,…”
    Get full text
    Journal Article
  5. 5

    Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer by Quan, M L, Sclafani, L, Heerdt, A S, Fey, J V, Morris, E A, Borgen, P I

    Published in Annals of surgical oncology (01-11-2003)
    “…Predicting the extent of disease in the breasts of patients with invasive lobular cancer (ILC) can be difficult because of the limits of physical examination…”
    Get full text
    Journal Article
  6. 6

    Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison by Turner, B T, Hampton, L, Schiller, D, Mack, L A, Robertson-More, C, Li, H, Quan, M L, Bouchard-Fortier, A

    Published in Current oncology (Toronto) (01-12-2019)
    “…Retroperitoneal sarcoma (rps) encompasses a heterogeneous group of malignancies with a high recurrence rate after resection. Neoadjuvant radiotherapy (nrt) is…”
    Get full text
    Journal Article
  7. 7

    A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study by Quan, M L, Olivotto, I A, Baxter, N N, Friedenreich, C M, Metcalfe, K, Warner, E, MacLennan, K, Stephen, J E, Akbari, M R, Howell, D, Narod, S

    Published in Current oncology (Toronto) (01-10-2020)
    “…The understanding of the biology and epidemiology of, and the optimal therapeutic strategies for, breast cancer (bca) in younger women is limited. We present…”
    Get full text
    Journal Article
  8. 8

    Taking the pulse of multidisciplinary cancer conferences for breast cancer care in Canada: A stocktake of current practice by Corter, A.L., Speller, B., Wright, F.C., Quan, M.L., Baxter, N.N.

    Published in Breast (Edinburgh) (01-04-2019)
    “…International guidelines highlight the importance of implementation supports and quality monitoring of multidisciplinary care for breast cancer. In Canada,…”
    Get full text
    Journal Article
  9. 9

    Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact by Bouchard-Fortier, A, Baxter, N N, Sutradhar, R, Fernandes, K, Camacho, X, Graham, P, Quan, M L

    Published in Current oncology (Toronto) (01-12-2018)
    “…Contralateral prophylactic mastectomy (cpm) has been increasingly common among women with unilateral invasive breast cancer (ibca) even though the data that…”
    Get full text
    Journal Article
  10. 10

    Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer by Laws, A, Cheifetz, R, Warburton, R, McGahan, C E, Pao, J S, Kuusk, U, Dingee, C, Quan, M L, McKevitt, E

    Published in Current oncology (Toronto) (01-10-2020)
    “…In response to Choosing Wisely recommendations that sentinel lymph node biopsy (slnb) should not be routinely performed in elderly patients with node-negative…”
    Get full text
    Journal Article
  11. 11

    Influences of Various Supports, γ-Al2O3, CeO2, and SBA-15 on HDO Performance of NiMo Catalyst by Phan, Binh M. Q., Ha, Quan L. M., Le, Nguyen P., Ngo, Phuong T., Nguyen, Thu H., Dang, Tung T., Nguyen, Luong H., Nguyen, Duc A., Luu, Loc C.

    Published in Catalysis letters (01-02-2015)
    “…Hydrodeoxygenation (HDO) of guaiacol (GUA), has been carried out over γ-Al 2 O 3 , CeO 2 , SBA-15 supported NiMo catalysts in an autoclave at 250 °C and a…”
    Get full text
    Journal Article
  12. 12

    Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2 by Quan, Mimi L, Ellis, Christopher D, Liauw, Ann Y, Alexander, Richard S, Knabb, Robert M, Lam, Gilbert, Wright, Matthew R, Wong, Pancras C, Wexler, Ruth R

    Published in Journal of medicinal chemistry (29-07-1999)
    “…Intravascular clot formation is an important factor in a number of cardiovascular diseases. Therefore, the prevention of blood coagulation has become a major…”
    Get full text
    Journal Article
  13. 13

    Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1 by Quan, Mimi L, Liauw, Ann Y, Ellis, Christopher D, Pruitt, James R, Carini, David J, Bostrom, Lori L, Huang, Peggy P, Harrison, Kimberly, Knabb, Robert M, Thoolen, Martin J, Wong, Pancras C, Wexler, Ruth R

    Published in Journal of medicinal chemistry (29-07-1999)
    “…Thrombosis is a major cause of mortality in the industrialized world. Therefore, the prevention of blood coagulation has become a major target for new…”
    Get full text
    Journal Article
  14. 14

    Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer-clinical examination, mammography, or magnetic resonance imaging? by Wright, F.C., Zubovits, J., Gardner, S., Fitzgerald, B., Clemons, M., Quan, M.L., Causer, P.

    Published in Journal of surgical oncology (01-06-2010)
    “…Purpose Accurate assessment of residual disease after neo‐adjuvant chemotherapy (NEC) for women with locally advanced and inflammatory breast cancer (LABC) is…”
    Get full text
    Journal Article
  15. 15

    Comparison of international breast cancer guidelines: are we globally consistent? cancer guideline AGREEment by Hogeveen, S E, Han, D, Trudeau-Tavara, S, Buck, J, Brezden-Masley, C B, Quan, M L, Simmons, C E

    Published in Current oncology (Toronto) (01-06-2012)
    “…Evidence-based guidelines are used in health care systems throughout the world to aid in treatment decisions and to ensure quality and consistency in patient…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors by Quan, M.L., Pruitt, J.R., Ellis, C.D., Liauw, A.Y., Galemmo, R.A., Stouten, P.F.W., Wityak, J., Knabb, R.M., Thoolen, M.J., Wong, P.C., Wexler, R.R.

    Published in Bioorganic & medicinal chemistry letters (04-11-1997)
    “…Factor Xa is an important serine protease in the blood coagulation cascade. It generates thrombin and holds the central position that links the intrinsic and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The design and synthesis of noncovalent factor Xa inhibitors by Quan, M L, Wexler, R R

    Published in Current topics in medicinal chemistry (01-06-2001)
    “…Thrombosis is a major cause of mortality in the industrialized world. Therefore, the control of blood coagulation has become a major target for new therapeutic…”
    Get more information
    Journal Article
  20. 20

    Effect of hydrothermal conditions on the catalytic deactivation of a fluid cracking catalyst by Nguyen, Thu H., Ngo, Phuong T., Tran, Tri V., Nguyen, Sura, Vu, Duy M., Ha, Quan L. M., Dao, Xuan T. T., Dang, Tung T.

    “…The laboratory deactivation technique Cyclic Propylene Steaming (CPS) method, conventionally used to simulate the performance of commercial FCC catalysts, is…”
    Get full text
    Journal Article